Direct Epidemio-Statistics helps to screen patient health indicators in silico for early risk markers, anticipate multifactorial adverse events using scoring, prioritize risks, and explore target populations more easily and quickly. Our risk expertise provides the following benefits:

Direct Epidemio-Statistics' quantitative risk expertise helps you search for early risk markers, model multifactorial causes of serious adverse events, better understand the pathogenesis of these risks, prioritize risks, and perform surveillance using population databases (Real World Evidence). Benefits include: